Mobile-health Network Solutions (MNDR) has secured $10 million in strategic funding through a Standby Equity Subscription Agreement with Yorkville to expand its AI-powered telehealth solutions across the Asia-Pacific region. The investment will specifically support development of the company's innovative AI Agent technology platform, which represents a significant advancement in healthcare technology through its use of real-time clinical decision support, multilingual natural language processing, and adaptive learning capabilities.
The AI Agent platform differs from traditional rule-based AI models by being designed to evolve continuously, maintaining alignment with medical professionals' changing needs and preferences. A recent pilot study conducted in Singapore demonstrated the platform's substantial potential, completing 6,000 consultations while showing remarkable efficiency gains for participating healthcare providers. Doctors involved in the pilot reported significant workflow improvements, with one participant noting a 50% reduction in administrative paperwork burden.
Early validation data from the Singapore pilot revealed particularly impressive results in consultation documentation accuracy, achieving 98% precision in capturing and recording clinical interactions. Dr. Siaw Tung Yeng, co-CEO of Mobile-health Network Solutions, emphasized the company's commitment to developing AI-driven solutions that genuinely support healthcare providers rather than replacing them. The strategic funding will enable MNDR to expand both its technological capabilities and market presence, with particular focus on Southeast Asian markets where digital healthcare adoption is accelerating rapidly.
The investment holds strategic importance for MNDR's growth trajectory, potentially translating into increased market share, revenue expansion, and improved investor returns. By maintaining focus on patient safety, clinical accuracy, and data security as foundational principles, the company aims to revolutionize telehealth services through advanced AI technology that enhances rather than disrupts existing healthcare workflows. The expansion comes at a critical time for digital health adoption across the Asia-Pacific region, where healthcare systems are increasingly seeking technological solutions to address growing patient demands and operational challenges.
